What Healthcare Could Look Like

Interview with Prof. Dr. Christian Schmidt, CEO of LifeLink Medical GmbH

Prof. Dr. Christian Schmidt, CEO of LifeLink Medical GmbH
Prof. Dr. Christian Schmidt, CEO of LifeLink Medical GmbH

LifeLink Medical GmbH has quickly established itself as a leading provider in the field of diagnostics and relies on innovative models to revolutionize outpatient care. CEO Prof. Dr. med. Christian Schmidt, a specialist in surgery, discusses with Wirtschaftsforum the strategy of LifeLink Medical and the importance of interdisciplinary cooperation, and explains how artificial intelligence helps shape the diagnostics of the future.

Wirtschaftsforum: Prof. Dr. Schmidt, you have been with LifeLink Medical GmbH for about eight months. What motivated you to take this step?

Prof. Dr. Christian Schmidt: My motivation was to develop new models of care, particularly in the area of outpatient services. There is a great need in rural regions. At LifeLink Medical, we have the opportunity to create innovative solutions for patients and bridge gaps in care.

Wirtschaftsforum: What distinguishes LifeLink Medical GmbH and what goals does the company pursue?

Prof. Dr. Christian Schmidt: LifeLink Medical has committed itself to offering Diagnostics as a Service. This means that we combine various specialties such as radiology, radiation therapy, nuclear medicine, and pathology, including highly specialized areas like molecular pathology and specialized laboratories. We rely on the latest technologies like Next-Generation Sequencing. Our goal is to offer diagnostics at the highest level and thus sustainably improve patient care.

LifeLink Medical GmbH Registration
LifeLink Medical GmbH connects modern practices with a high degree of specialization for modern and sustainable patient care

Wirtschaftsforum: How has the development of LifeLink Medical progressed?

Prof. Dr. Christian Schmidt: The company was founded about a year and a half ago. Initially, we focused on x-ray practices, but quickly expanded into radiation therapy and nuclear medicine. Today, we are the market leader in the Aachen region and in Aachen itself. Since the beginning of this year, we have further refined our strategy and now offer comprehensive diagnostic services that include not only radiology but also areas like pathology and cardiology.

LifeLink Medical GmbH Registration

Wirtschaftsforum: What distinguishes LifeLink Medical from other providers in healthcare?

Prof. Dr. Christian Schmidt: We pursue a long-term, scalable approach that sets us apart from many competitors. Our DNA is to develop sustainable, regional supply models that work particularly well in rural areas. In addition, we employ people who have a variety of experiences, including from hospital management, thus bringing the necessary mix of competencies. This expertise is incorporated into the design of our care processes.

LifeLink Medical GmbH Registration
LifeLink Medical GmbH Specialization
LifeLink Medical deliberately focuses on practices with a high degree of specialization

Wirtschaftsforum: What is the current structure of LifeLink Medical?

Prof. Dr. Christian Schmidt: We currently have over 1,000 employees and are represented in various regions of Germany, such as East Westphalia and Bielefeld, where we are also market leaders. Currently, we are also building a large cluster in the Lower Rhine area and have locations planned from Aschaffenburg to Darmstadt as well as in Munich. Our specialties include radiotherapy, radiology, nuclear medicine, and pathology. We deliberately focus on practices with a high level of specialization and academic spirit, which allows us to offer nationally recognized expertise.

LifeLink Medical GmbH Radiology
Radiology is one of the specialties of LifeLink Medical

Wirtschaftsforum: What role does interdisciplinarity play at LifeLink Medical?

Prof. Dr. Christian Schmidt: Interdisciplinary work is a central aspect for us. Cases are discussed across several disciplines, which allows for better diagnostics and therapy. One challenge is to represent and manage this collaboration regionally. We rely on a common software system that facilitates communication and exchange between the disciplines, thus offering the patient a high level of treatment comfort.

LifeLink Medical GmbH Diagnostics
The goal is to offer diagnostics at the highest level and thus sustainably improve patient care

Wirtschaftsforum: What philosophy does LifeLink Medical follow regarding innovation and digitalization?

Prof. Dr. Christian Schmidt: We firmly believe in the power of digitalization and innovation. One example is the use of artificial intelligence (AI) in our practices. Our practice software works with an AI-supported call center system that helps us with scheduling and data querying. We also rely on AI in imaging diagnostics, for example in Cardio-CT, to further improve diagnostics.

Wirtschaftsforum: What are your long-term goals for LifeLink Medical?

Prof. Dr. Christian Schmidt: We want to grow organically, develop regional comprehensive care models, and further advance digitalization. Our goal is to extend the care chain for the patient and, following diagnostics, also offer therapy and aftercare. This could eventually extend into the homecare sector. Our focus remains on regional care, which is supported by digital solutions but always close to the patient. We also want to train our own staff, especially in specialized sub-disciplines, to ensure high-quality long-term care.

More Articles on Topic

Relief for Blind and Visually Impaired People Through AI

Interview with Klaus Knüpfer, CEO of EV Optron GmbH

Relief for Blind and Visually Impaired People Through AI

EV Optron is recognized as a manufacturer of products for blind users as well as reading and reading aloud devices for people with visual impairments: a Te...

MedTech with Responsibility – Solutions that Connect

Interview with Laura Garcia Baglietto, Executive Vice President Medical Devices & Environment International of the GBA Group and Dr. Timo Lebold, Managing Director of GBA MDS GmbH

MedTech with Responsibility – Solutions that Connect

The GBA Group is one of the leading laboratory and consulting service providers in the European Life Sciences sector. In Gilching near Munich, GBA M...

More than 'just' similar

Interview with Mag. Helmut Kaisergruber, Managing Director and Co-owner, and Dr. Sabine Möritz-Kaisergruber, Managing Director and Co-owner of Astro Pharma GmbH

More than 'just' similar

Biosimilars, high-quality subsequent products of biologics, are increasingly gaining importance in the international health market. As a cost-effective...

Meeting patients at their needs

Interview with Alexander Fröhlich, Vice President DACH and General Manager of Dexcom Deutschland GmbH and Dr. Michael Struck, Marketing Director DACH of Dexcom Deutschland GmbH

Meeting patients at their needs

Easing the daily life of people with diabetes is the goal of Dexcom Deutschland GmbH. The globally successful corporation Dexcom is one of the market leaders...

Manfred Brinkmann, Managing Editor-in-Chief

Manfred Brinkmann

Managing Editor of European Business

Are You Shaping the Future of Business?

As Managing Editor-in-Chief, I am always searching for the next generation of leaders and innovators. If you are at the helm of a company making a significant impact, I invite you to connect with us. Let's share your vision with our audience of influentia.